Jun 25 |
From Sci-Fi Dream to Market Maze: Eli Lilly's Weight-Loss Medication Faces Hurdles
|
Jun 25 |
Lilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteria
|
Jun 25 |
Is Eli Lilly (LLY) a Buy on Tirzepatide Success in Sleep Apnea?
|
Jun 25 |
Novo to spend $4B on US plant, adding to obesity drug production push
|
Jun 25 |
Company News for Jun 25, 2024
|
Jun 24 |
Why Investors Haven't Feasted on Two New Weight-Loss ETFs
|
Jun 24 |
Crypto under pressure, Good Buy or Goodbye: Market Domination
|
Jun 24 |
Novo Nordisk to invest $4.1B in NC facility for GLP-1 drugs
|
Jun 24 |
Lilly Weight-Loss Drug Data Spurs Selloff in Sleep Apnea Stocks
|
Jun 24 |
It's Not Just a Bad Day for Chip Stocks. ResMed Is the S&P 500’s Top Decliner.
|